Note*: This report requires 7-10 business days to complete.
DelveInsight’s Major Depressive Disorder - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Major Depressive Disorder forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Major Depressive Disorder till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Major Depressive Disorder market.
• Identifying patient populations in the global “Major Depressive Disordermarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Major Depressive Disorder therapeutics in each of the markets covered.
• To understand the future market competition in the global Major Depressive Disorder therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Major Depressive Disorder for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Major Depressive Disorder overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Major Depressive Disorder Market
• Global Epidemiology of Major Depressive Disorder Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Major Depressive Disorder Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Major Depressive Disorder (2013-2023)
• Table 7: Major Depressive Disorder Global Market (USD Millions), (2013-2015)
• Table 8: Major Depressive Disorder Global Market (USD Millions), (2016-2023)
• Table 9: Major Depressive Disorder US Market (USD Millions), (2013-2015)
• Table 10: Major Depressive Disorder US Market (USD Millions), (2016-2023)
• Table 11: Major Depressive Disorder Germany Market (USD Millions), (2013-2015)
• Table 12: Major Depressive Disorder Germany Market (USD Millions), (2016-2023)
• Table 13: Major Depressive Disorder United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Major Depressive Disorder United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Major Depressive Disorder France Market (USD Millions), (2013-2015)
• Table 16: Major Depressive Disorder France Market (USD Millions), (2016-2023)
• Table 17: Major Depressive Disorder Italy Market (USD Millions), (2013-2015)
• Table 18: Major Depressive Disorder Italy Market (USD Millions), (2016-2023)
• Table 19: Major Depressive Disorder Spain Market (USD Millions), (2013-2015)
• Table 20: Major Depressive Disorder Spain Market (USD Millions), (2016-2023)
• Table 21: Major Depressive Disorder Japan Market (USD Millions), (2013-2015)
• Table 22: Major Depressive Disorder Japan Market (USD Millions), (2016-2023)
• Table 23: Major Depressive Disorder ROW Market (USD Millions), (2013-2015)
• Table 24: Major Depressive Disorder ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Major Depressive Disorder Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Major Depressive Disorder (2013-2023)
• Figure 3: Major Depressive Disorder Global Market (USD Millions), (2013-2015)
• Figure 4: Major Depressive Disorder Global Market (USD Millions), (2016-2023)
• Figure 5: Major Depressive Disorder US Market (USD Millions), (2013-2015)
• Figure 6: Major Depressive Disorder US Market (USD Millions), (2016-2023)
• Figure 7: Major Depressive Disorder Germany Market (USD Millions), (2013-2015)
• Figure 8: Major Depressive Disorder Germany Market (USD Millions), (2016-2023)
• Figure 9: Major Depressive Disorder United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Major Depressive Disorder United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Major Depressive Disorder France Market (USD Millions), (2013-2015)
• Figure 12: Major Depressive Disorder France Market (USD Millions), (2016-2023)
• Figure 13: Major Depressive Disorder Italy Market (USD Millions), (2013-2015)
• Figure 14: Major Depressive Disorder Italy Market (USD Millions), (2016-2023)
• Figure 15: Major Depressive Disorder Spain Market (USD Millions), (2013-2015)
• Figure 16: Major Depressive Disorder Spain Market (USD Millions), (2016-2023)
• Figure 17: Major Depressive Disorder Japan Market (USD Millions), (2013-2015)
• Figure 18: Major Depressive Disorder Japan Market (USD Millions), (2015-2023)
• Figure 19: Major Depressive Disorder ROW Market (USD Millions), (2013-2015)
• Figure 20: Major Depressive Disorder ROW Market (USD Millions), (2016-2023)
• Lundbeck
• Forest Laboratories (Actavis)
• Eli Lilly
• Pfizer
• Otsuka Pharmaceutical
• AstraZeneca
• Takeda Pharmaceutical
• Alkermes
• Euthymics Bioscience
• Naurex
• e-Therapeutics
